InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,474.66
(
0.03%
)
US TECH 100
19,363.40
(
-0.20%
)
Dow Jones
38,764.32
(
-0.04%
)
Brent Oil
84.63
(
0.86%
)
Bitcoin
64,513.91
(
-2.97%
)
Post# of 252237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: biomaven0 post# 143015

Monday, 06/04/2012 2:20:22 AM

Monday, June 04, 2012 2:20:22 AM

Post# of 252237

The MDVN trial is much bigger, and they will clearly hit stat sig on OS.

Peter, don't you think there's a risk that the PREVAIL trial of MDV3100 in chemotherapy-naive CRPC patients will not hit stat-sig on OS because of crossover?
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up